nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AA amyloidosis without systemic inflammation: when clinical evidence validates predictions of experimental medicine
|
Obici, Laura |
|
|
101 |
2 |
p. 219-221 |
artikel |
2 |
Acute methotrexate-induced crystal nephropathy
|
Blum, Matthew F. |
|
|
101 |
2 |
p. 424 |
artikel |
3 |
Addressing screams for evidence on renoprotection by GLP-1 receptor agonists
|
Sasako, Takayoshi |
|
|
101 |
2 |
p. 222-224 |
artikel |
4 |
Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease
|
Kaesler, Nadine |
|
|
101 |
2 |
p. 338-348 |
artikel |
5 |
A metabolomics approach identified toxins associated with uremic symptoms in advanced chronic kidney disease
|
Hu, Jiun-Ruey |
|
|
101 |
2 |
p. 369-378 |
artikel |
6 |
A mutation in the SAA1 promoter causes hereditary amyloid A amyloidosis
|
Sikora, Jakub |
|
|
101 |
2 |
p. 349-359 |
artikel |
7 |
Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis
|
Kant, Sam |
|
|
101 |
2 |
p. 414-415 |
artikel |
8 |
Anti-CD38 therapy for PLA2R-positive membranous nephropathy resistant to conventional immunosuppression
|
Stehlé, Thomas |
|
|
101 |
2 |
p. 416-418 |
artikel |
9 |
A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis
|
Espi, Maxime |
|
|
101 |
2 |
p. 390-402 |
artikel |
10 |
A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis
|
Rovin, Brad H. |
|
|
101 |
2 |
p. 403-413 |
artikel |
11 |
A systematic review and meta-analysis of murine models of uremic cardiomyopathy
|
Soppert, Josefin |
|
|
101 |
2 |
p. 256-273 |
artikel |
12 |
BLISS-LN trial revisited: function matters
|
Gleeson, Sarah |
|
|
101 |
2 |
p. 224-226 |
artikel |
13 |
Corrigendum to Cai J, Liu Z, Huang X, et al. The deacetylase sirtuin 6 protects against kidney fibrosis by epigenetically blocking β-catenin target gene expression Kidney Int. 2020;97:106–118
|
|
|
|
101 |
2 |
p. 422 |
artikel |
14 |
Deep learning identified pathological abnormalities predictive of graft loss in kidney transplant biopsies
|
Yi, Zhengzi |
|
|
101 |
2 |
p. 288-298 |
artikel |
15 |
Dephosphorylation of AMP-activated protein kinase exacerbates ischemia/reperfusion-induced acute kidney injury via mitochondrial dysfunction
|
Ma, Haijian |
|
|
101 |
2 |
p. 315-330 |
artikel |
16 |
Diagnosis of AApoAIV medullary amyloidosis at radical nephrectomy
|
Rosenstiel, Paul E. |
|
|
101 |
2 |
p. 423 |
artikel |
17 |
Distinct glomerular disease association after vaccination with BNT162b2 and mRNA-1273: a VigiBase analysis
|
Kronbichler, Andreas |
|
|
101 |
2 |
p. 415-416 |
artikel |
18 |
Editorial Board
|
|
|
|
101 |
2 |
p. A1 |
artikel |
19 |
GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes
|
Xu, Yang |
|
|
101 |
2 |
p. 360-368 |
artikel |
20 |
Insights into vitamin K metabolism in chronic kidney disease: more complicated than kale deficiency
|
Lees, Jennifer S. |
|
|
101 |
2 |
p. 216-219 |
artikel |
21 |
In this issue
|
|
|
|
101 |
2 |
p. 195 |
artikel |
22 |
Journal Club
|
|
|
|
101 |
2 |
p. 205-207 |
artikel |
23 |
KDIGO recommendations for the evaluation of glycemic control in advanced chronic kidney disease
|
Fonseca, Vivian |
|
|
101 |
2 |
p. 420 |
artikel |
24 |
Lipoic acid in neural epidermal growth factor-like 1–associated membranous nephropathy: more than a coincidence?
|
Caza, Tiffany N. |
|
|
101 |
2 |
p. 418-419 |
artikel |
25 |
Modulation of transforming growth factor-β-induced kidney fibrosis by leucine-rich ⍺-2 glycoprotein-1
|
Hong, Quan |
|
|
101 |
2 |
p. 299-314 |
artikel |
26 |
Murine models of uremic cardiomyopathy as a necessary tool to unravel mechanisms involved in cardiorenal syndrome
|
Navarro-García, José Alberto |
|
|
101 |
2 |
p. 214-216 |
artikel |
27 |
Noninvasive screening of vancomycin-associated cast nephropathy
|
Rafat, Cédric |
|
|
101 |
2 |
p. 425 |
artikel |
28 |
Prediction models of treatment response in lupus nephritis
|
Ayoub, Isabelle |
|
|
101 |
2 |
p. 379-389 |
artikel |
29 |
RNA-based immunoglobulin repertoire sequencing is a new tool for the management of monoclonal gammopathy of renal (kidney) significance
|
Javaugue, Vincent |
|
|
101 |
2 |
p. 331-337 |
artikel |
30 |
Running interference: lumasiran and other RNA interference therapeutics for kidney diseases
|
Massy, Ziad A. |
|
|
101 |
2 |
p. 208-211 |
artikel |
31 |
Sema4A-Nrp1 versus Sema4A-plexinB2 in the acutely damaged kidney
|
Calmont, Amélie |
|
|
101 |
2 |
p. 419 |
artikel |
32 |
Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy
|
Cambier, Alexandra |
|
|
101 |
2 |
p. 274-287 |
artikel |
33 |
Subscription Information
|
|
|
|
101 |
2 |
p. A3 |
artikel |
34 |
Table of Contents
|
|
|
|
101 |
2 |
p. A7, A9, A11, A13 |
artikel |
35 |
The authors reply:
|
Caramori, M. Luiza |
|
|
101 |
2 |
p. 420-421 |
artikel |
36 |
The authors reply:
|
Li, Xiubin |
|
|
101 |
2 |
p. 419-420 |
artikel |
37 |
The Case | An unusual cause of renal vascular thrombi after kidney transplantation
|
Erpicum, Pauline |
|
|
101 |
2 |
p. 427-428 |
artikel |
38 |
The changing role of glucocorticoids in the treatment of anti–neutrophil cytoplasmic antibody–associated vasculitis
|
Dhaun, Neeraj |
|
|
101 |
2 |
p. 201-204 |
artikel |
39 |
The lupus nephritis management renaissance
|
Mejia-Vilet, Juan M. |
|
|
101 |
2 |
p. 242-255 |
artikel |
40 |
Untangling the fibers of sarcopenia: activin A in chronic kidney disease–associated muscle wasting
|
Terker, Andrew S. |
|
|
101 |
2 |
p. 211-213 |
artikel |
41 |
Uremic encephalopathy
|
Rosner, Mitchell H. |
|
|
101 |
2 |
p. 227-241 |
artikel |
42 |
Urine, doctors, and the acanthocyte’s 30th birthday
|
Kraus, Daniel |
|
|
101 |
2 |
p. 196-200 |
artikel |